EE9900385A - Zopolrestaat-monohüdraadi polümorfne vorm, selle kasutamine ja valmistamise protsess - Google Patents

Zopolrestaat-monohüdraadi polümorfne vorm, selle kasutamine ja valmistamise protsess

Info

Publication number
EE9900385A
EE9900385A EEP199900385A EEP9900385A EE9900385A EE 9900385 A EE9900385 A EE 9900385A EE P199900385 A EEP199900385 A EE P199900385A EE P9900385 A EEP9900385 A EE P9900385A EE 9900385 A EE9900385 A EE 9900385A
Authority
EE
Estonia
Prior art keywords
preparation
polymorphic form
zopolrestat monohydrate
zopolrestat
monohydrate
Prior art date
Application number
EEP199900385A
Other languages
English (en)
Estonian (et)
Inventor
Francis Lambert John
Norris Timothy
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of EE9900385A publication Critical patent/EE9900385A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
EEP199900385A 1998-08-21 1999-08-19 Zopolrestaat-monohüdraadi polümorfne vorm, selle kasutamine ja valmistamise protsess EE9900385A (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9747498P 1998-08-21 1998-08-21

Publications (1)

Publication Number Publication Date
EE9900385A true EE9900385A (et) 2000-04-17

Family

ID=22263562

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900385A EE9900385A (et) 1998-08-21 1999-08-19 Zopolrestaat-monohüdraadi polümorfne vorm, selle kasutamine ja valmistamise protsess

Country Status (31)

Country Link
US (1) US6159976A (is)
EP (1) EP0982306A3 (is)
JP (1) JP2000072769A (is)
KR (1) KR20000017411A (is)
CN (1) CN1245804A (is)
AP (1) AP9901662A0 (is)
AU (1) AU4453299A (is)
BG (1) BG103674A (is)
BR (1) BR9903873A (is)
CA (1) CA2280590A1 (is)
EA (1) EA199900675A3 (is)
EE (1) EE9900385A (is)
GT (1) GT199900137A (is)
HR (1) HRP990259A2 (is)
HU (1) HUP9902783A3 (is)
ID (1) ID23307A (is)
IL (1) IL131419A0 (is)
IS (1) IS5155A (is)
MA (1) MA26678A1 (is)
NO (1) NO994027L (is)
NZ (1) NZ337363A (is)
OA (1) OA11150A (is)
PA (1) PA8480601A1 (is)
PE (1) PE20000993A1 (is)
PL (1) PL335016A1 (is)
SG (1) SG83147A1 (is)
TN (1) TNSN99159A1 (is)
TR (1) TR199901996A2 (is)
UY (1) UY25668A1 (is)
YU (1) YU39899A (is)
ZA (1) ZA995297B (is)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12653825B2 (en) 2010-07-16 2026-06-16 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
US8916563B2 (en) 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
HUE031506T2 (en) 2010-07-16 2017-07-28 Univ Columbia Aldose reductase inhibitors and their use
US20140228319A1 (en) * 2013-02-13 2014-08-14 Banavara L. Mylari Water soluble salts of aldose reductase inhibitors for treatment of diabetic complications
ES2966094T3 (es) 2016-06-21 2024-04-18 Univ Columbia Compuestos 4-oxo-3,4-dihidrotieno[3,4-d]piridazina como inhibidores de la aldosa reductasa y métodos de uso de los mismos
IL272246B2 (en) 2017-07-28 2026-01-01 Applied Therapeutics Inc History of 2-(4-oxo/thioketone/azo-3-((substituted)benzo[d]thiazol-2-yl)methyl)- 3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid for use as an aldose reductase inhibitor for the treatment of galactosemia or prevention of galactosemia-related complications
CN113840825A (zh) 2019-04-01 2021-12-24 应用治疗公司 醛糖还原酶抑制剂
MX2021013511A (es) 2019-05-07 2022-02-23 Univ Miami Tratamiento y deteccion de neuropatias heredadas y trastornos asociados.
WO2021202523A1 (en) 2020-03-31 2021-10-07 Applied Therapeutics, Inc. Aldose reductase inhibitors for the treatment of acute respiratory distress syndrome, acute lung inflammation/injury, cardiac injury and anti-viral therapy
KR20230005944A (ko) 2020-05-01 2023-01-10 어플라이드 테라퓨틱스 인크. 소르비톨 데히드로게나제 결핍 치료를 위한 알도스 리덕타제 억제제
EP4211136B1 (en) * 2020-09-08 2025-08-20 Assia Chemical Industries Ltd. Solid state forms of at-001 and process for preparation thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748280A (en) * 1985-11-07 1988-05-31 Pfizer Inc. Certain chlorination process for preparing 2-chloro-1,1,1-(C1 -C6)
US4939140A (en) * 1985-11-07 1990-07-03 Pfizer Inc. Heterocyclic oxophthalazinyl acetic acids
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法
US4868301A (en) * 1987-06-09 1989-09-19 Pfizer Inc. Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains
US4904782A (en) * 1988-02-29 1990-02-27 Pfizer Inc. Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
WO1992003432A1 (en) * 1990-08-28 1992-03-05 Pfizer Inc. 3-(5-trifluoromethylbenzothiazol-2-ylmethyl)-4-oxo-3h-phythalazin-1-ylacetic acid monohydrate
US5391551A (en) * 1993-05-10 1995-02-21 Pfizer Inc. Method of lowering blood lipid levels
IL120264A0 (en) * 1996-02-29 1997-06-10 Pfizer Method of reducing tissue damage associated with non-cardiac ischemia

Also Published As

Publication number Publication date
EA199900675A2 (ru) 2000-02-28
YU39899A (sh) 2002-12-10
PE20000993A1 (es) 2000-10-04
BG103674A (en) 2000-03-31
GT199900137A (es) 2001-02-09
IS5155A (is) 2000-02-22
OA11150A (en) 2003-04-16
EP0982306A3 (en) 2000-07-05
HUP9902783A3 (en) 2001-01-29
NO994027L (no) 2000-02-22
PA8480601A1 (es) 2000-09-29
TR199901996A2 (xx) 2000-03-21
HRP990259A2 (en) 2000-06-30
CN1245804A (zh) 2000-03-01
HUP9902783A2 (hu) 2000-12-28
PL335016A1 (en) 2000-02-28
HU9902783D0 (en) 1999-10-28
AU4453299A (en) 2000-03-09
US6159976A (en) 2000-12-12
EP0982306A2 (en) 2000-03-01
CA2280590A1 (en) 2000-02-21
SG83147A1 (en) 2001-09-18
EA199900675A3 (ru) 2000-06-26
BR9903873A (pt) 2000-09-19
NZ337363A (en) 2001-01-26
JP2000072769A (ja) 2000-03-07
ZA995297B (en) 2001-02-19
ID23307A (id) 2000-04-05
NO994027D0 (no) 1999-08-20
AP9901662A0 (en) 1999-09-30
TNSN99159A1 (fr) 2005-11-10
KR20000017411A (ko) 2000-03-25
IL131419A0 (en) 2001-01-28
UY25668A1 (es) 2001-08-27
MA26678A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
EE03489B1 (et) Olansapiini polümorfne vorm II, selle saamismeetod ja farmatseutiline preparaat
NO20030163L (no) Fremgangsmate for fremstilling av olefiner
EE200100574A (et) Uued ühendid, nende valmistamise meetod ning kasutamine
ITMI20000546A0 (it) Processo per la preparazione di 1-esene
EE04234B1 (et) L-fenüülefriinvesinikkloriidi valmistamise meetod
NO20005000D0 (no) FremgangsmÕte for fremstilling av rÕstoffer for glassfremstilling
NO20026155D0 (no) Fremgangsmåte for fremstilling av lavere olefiner
NO994027D0 (no) Polymorf av zopolrestat-monohydrat
EE200100573A (et) Uued ühendid, nende valmistamise meetod ning kasutamine
NO20000965D0 (no) Fremgangsmåte for fremstilling av veksthormon-utskillende forbindelser
EE200200014A (et) Dibensotiasepiiniderivaatide valmistamismeetod
NO20013407D0 (no) Fremgangsmåte for fremstilling av kinolinkarbaldehyd
ITMI991731A0 (it) Processo per la preparazione di derivati 3-sostituiti di 4-fenil-piper idine
NO20020308D0 (no) Fremgangsmåte for fremstilling av epothiolon B og derivater, såvel som mellomprodukter for fremgangsmåten
NO20014383L (no) Fremgangsmåte for fremstilling av syklo-(Asp-DPhe-NMeVal-Arg- Gly)
NO20000805D0 (no) Fremgangsmåte for fremstilling av organiske azider
ITMI992127A0 (it) Processo per la preparazione di un composto aril-piridinico
ITMI20000261A0 (it) Processo per la preparazione di piridiniliden-ftalidi
IT1312105B1 (it) Procedimento per ottenere pentafluoroetano per dismutazione daclorotetrafluoroetano
NO20032297L (no) Fremgangsmåte for fremstilling av distamycinderivater
NO20013044D0 (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
EE200000369A (et) Isopropüülmetüül[2-(3-n-propoksüfenoksü)etüül]amiini valmistamise protsess
IT1312104B1 (it) Processo per ottenere pentafluoroetano per dismutazione ditetrafluorocloretano
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol